Abstract
Although the term profit making in medicine carries negative connotations for many people, there is little doubt that in dialysis the co-operation between industry, always willing to make a profit, entrepreneurial physicians, and recently institutions driven to find monetary support, have lead to more patients being accepted and treated in the United States than anywhere in the world. In 1989 almost 200 patients/million were accepted for dialysis in the USA, the runner up Japan accepted around 150 and there is no European country as yet who has broken the 100 pt/million barrier for the treatment of End Stage Renal Failure (ESRD).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Rettig, R A. Origins of the Medicare disease entitlement. The Social Security Amendments of 1972. In Hanna K (ed): Biomedical Politics Washington D.C., Academy Press 1991: pp. 176–208.
Shapiro, FL, Messner R, Smith, HT. Satellite haemodialysis. Ann Intern Med 1968; 69: 673–84.
Hampers Constantine. Personal communications.
Hull, AR, Parker TF. Introduction and summary of the proceedings from the morbidity, mortality, and prescription of dialysis sumposium. Dallas, Texas, September 15–17, 1989. Am J Kidney Dis 1990; XV (5): 375–83.
Brunner FP, Selwood NH. Results of renal replacement therapy in Europe 1980–87. Am J Kidney Dis 1990; XV (5): 384–96.
Kjellstrand C, Hylander B, Collins AC. Mortality in dialysis — On the influence of early start, patient characteristics, and transplantation and acceptance rates. Am J Kidney Dis 1990; XV(5): 483–90.
Brunner F. personal communications.
Odaka Michio, personal communications.
United States Renal Data System. Annual Report 1990; p. 68.
United States Renal Data Systems. Gold Notes, Figure 14, September 15, 1990.
Federal Registry
Held PJ, Bovbjerg RR, Pauly MV et al. Effect of the 1983 composite rate changes on ESRD patients, providers, and spending. Urban Institute: Washington D.C., December 21, 1987.
Wolfe RA., Port FK, Hawthorne MV et al. Comparison of survival among dialytic therapies of choice in center hemodialysis vs continuous ambulatory peritoneal dialysis at home. Am J Kidney Dis 1990; XV: 433–440, May.
Kjellstrand CM, personal communications.
Ile M. When health care payers have market power. JAMA 1990; 263 (14).
Rettig RA, personal communications.
Their S. Presentation, invited lecturer at the American Society of Nephrology, Washington, D.C., December, 1990.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hull, A.R. (1992). ‘For-profit’ and ‘not-for-profit’ dialysis: cost cutting and solutions in the USA. In: Kjellstrand, C.M., Dossetor, J.B. (eds) Ethical problems in dialysis and transplantation. Developments in Nephrology, vol 33. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-7969-8_6
Download citation
DOI: https://doi.org/10.1007/978-94-015-7969-8_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-4131-9
Online ISBN: 978-94-015-7969-8
eBook Packages: Springer Book Archive